HEY1 and familial pancreatic carcinoma: We found that QYHJ downregulated Hes-1 expression and Hey-1 expression in both mRNA level and protein level, which was more effective than gemcitabine treatment, indicating that QYHJ may inhibit pancreatic cancer through targeting Hes-1 and Hey-1.